SCHEMBL16484640

SCHEMBL16484640

c1ccc(-n2c3ccccc3c3c4sc5c(ccc6c5c5ccccc5n6-c5ncncn5)c4ccc32)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ JAK2 O60674 1/20 0.31
▸ JAK3 P52333 1/20 0.31
▸ HTT P42858 2/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ OPRD1 P41143 1/20 0.31
▸ OPRK1 P41145 1/20 0.31
▸ PAX8 Q06710 1/20 0.31
▸ TLR9 Q9NR96 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ MEN1 O00255 1/20 0.30
▸ USP2 O75604 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16484671 0.90 L3MBTL1 (0.45) KDM4EATML3MBTL1JAK2JAK3
SCHEMBL17989901 0.88 L3MBTL1 (0.49) KDM4EATML3MBTL1JAK2JAK3
SCHEMBL17245396 0.88 L3MBTL1 (0.52) KDM4EATML3MBTL1JAK2JAK3
SCHEMBL11932984 0.86 L3MBTL1 (0.57) KDM4EATML3MBTL1JAK2JAK3
SCHEMBL17246479 0.86 LIMK1 (0.35) HTTMAPTPAX8
SCHEMBL16484302 0.84 KDM4E (0.45) KDM4EATML3MBTL1JAK2JAK3
SCHEMBL17989865 0.83 KDM4E (0.46) KDM4EATML3MBTL1JAK2JAK3
SCHEMBL14951522 0.82 L3MBTL1 (0.52) KDM4EATML3MBTL1JAK2JAK3
SCHEMBL16483803 0.82 KDM4E (0.42) KDM4EATML3MBTL1JAK2JAK3
SCHEMBL10027539 0.82 L3MBTL1 (0.45) KDM4EATML3MBTL1HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9960364-B2 Ladder compound, and organic electroluminescent element using same IDEMITSU KOSAN CO., LTD. (JP) 2018-05-01 — — US disclosed
US-9960364-B2 Ladder compound, and organic electroluminescent element using same IDEMITSU KOSAN CO., LTD. (JP) 2018-05-01 — — US disclosed
US-20150270496-A1 LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMIITSU KOSAN CO., LTD. (JP) 2015-09-24 — — US disclosed
US-20150270496-A1 LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMIITSU KOSAN CO., LTD. (JP) 2015-09-24 — — US disclosed
WO-2014057684-A1 LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME 出光興産株式会社 (JP) 2014-04-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150270496-A1 LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME YBX1, ATXN2L, ATXN2 KDM4E 2405/4885ATM 3393/4885L3MBTL1 106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback